 | • レポートコード：QYR2104Z0081 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、急性期脊髄損傷のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（実験室試験、画像試験）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性期脊髄損傷の市場動向 ・企業の競争状況、市場シェア ・急性期脊髄損傷の種類別市場規模（実験室試験、画像試験） ・急性期脊髄損傷の用途別市場規模（病院、クリニック） ・急性期脊髄損傷の北米市場規模2016-2027（アメリカ、カナダ） ・急性期脊髄損傷のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性期脊髄損傷のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性期脊髄損傷の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性期脊髄損傷の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Oxygen Biotherapeutics、BioAxone BioSciences、AOSpine International、Neuronax、K-Stemcell、Asterias Biotherapeutics） ・結論 |
Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children.
The treatment of acute spinal cord injury is dependent on few factors such as age, health, medical history, severity of spinal cord injury, type of spinal cord injury and extent of psychological recovery. The treatment regime of acute spinal cord injury consists of medical management and observation in intensive care unit (ICU), corticosteroids to decrease the swelling, mechanical ventilator, bladder catheter and feeding tube. The treatments available against acute spinal cord injury are anterior cervical discectomy (ACDF), total disc arthroplasty, cervical laminoplasty, posterior aminotomy microdiscectomy, lumbar decompression, lumbar fusion and kyphoplasty.
Market Analysis and Insights: Global Acute Spinal Cord Injury Market
The global Acute Spinal Cord Injury market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Spinal Cord Injury market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Spinal Cord Injury market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Spinal Cord Injury market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Spinal Cord Injury market.
Global Acute Spinal Cord Injury Scope and Market Size
Acute Spinal Cord Injury market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Spinal Cord Injury market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laboratory Tests
Imaging Tests
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Oxygen Biotherapeutics
BioAxone BioSciences
AOSpine International
Neuronax
K-Stemcell
Asterias Biotherapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Spinal Cord Injury Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laboratory Tests
1.2.3 Imaging Tests
1.3 Market by Application
1.3.1 Global Acute Spinal Cord Injury Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Spinal Cord Injury Market Perspective (2016-2027)
2.2 Acute Spinal Cord Injury Growth Trends by Regions
2.2.1 Acute Spinal Cord Injury Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Spinal Cord Injury Historic Market Share by Regions (2016-2021)
2.2.3 Acute Spinal Cord Injury Forecasted Market Size by Regions (2022-2027)
2.3 Acute Spinal Cord Injury Industry Dynamic
2.3.1 Acute Spinal Cord Injury Market Trends
2.3.2 Acute Spinal Cord Injury Market Drivers
2.3.3 Acute Spinal Cord Injury Market Challenges
2.3.4 Acute Spinal Cord Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Spinal Cord Injury Players by Revenue
3.1.1 Global Top Acute Spinal Cord Injury Players by Revenue (2016-2021)
3.1.2 Global Acute Spinal Cord Injury Revenue Market Share by Players (2016-2021)
3.2 Global Acute Spinal Cord Injury Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Spinal Cord Injury Revenue
3.4 Global Acute Spinal Cord Injury Market Concentration Ratio
3.4.1 Global Acute Spinal Cord Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Spinal Cord Injury Revenue in 2020
3.5 Acute Spinal Cord Injury Key Players Head office and Area Served
3.6 Key Players Acute Spinal Cord Injury Product Solution and Service
3.7 Date of Enter into Acute Spinal Cord Injury Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Spinal Cord Injury Breakdown Data by Type
4.1 Global Acute Spinal Cord Injury Historic Market Size by Type (2016-2021)
4.2 Global Acute Spinal Cord Injury Forecasted Market Size by Type (2022-2027)
5 Acute Spinal Cord Injury Breakdown Data by Application
5.1 Global Acute Spinal Cord Injury Historic Market Size by Application (2016-2021)
5.2 Global Acute Spinal Cord Injury Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Spinal Cord Injury Market Size (2016-2027)
6.2 North America Acute Spinal Cord Injury Market Size by Type
6.2.1 North America Acute Spinal Cord Injury Market Size by Type (2016-2021)
6.2.2 North America Acute Spinal Cord Injury Market Size by Type (2022-2027)
6.2.3 North America Acute Spinal Cord Injury Market Size by Type (2016-2027)
6.3 North America Acute Spinal Cord Injury Market Size by Application
6.3.1 North America Acute Spinal Cord Injury Market Size by Application (2016-2021)
6.3.2 North America Acute Spinal Cord Injury Market Size by Application (2022-2027)
6.3.3 North America Acute Spinal Cord Injury Market Size by Application (2016-2027)
6.4 North America Acute Spinal Cord Injury Market Size by Country
6.4.1 North America Acute Spinal Cord Injury Market Size by Country (2016-2021)
6.4.2 North America Acute Spinal Cord Injury Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acute Spinal Cord Injury Market Size (2016-2027)
7.2 Europe Acute Spinal Cord Injury Market Size by Type
7.2.1 Europe Acute Spinal Cord Injury Market Size by Type (2016-2021)
7.2.2 Europe Acute Spinal Cord Injury Market Size by Type (2022-2027)
7.2.3 Europe Acute Spinal Cord Injury Market Size by Type (2016-2027)
7.3 Europe Acute Spinal Cord Injury Market Size by Application
7.3.1 Europe Acute Spinal Cord Injury Market Size by Application (2016-2021)
7.3.2 Europe Acute Spinal Cord Injury Market Size by Application (2022-2027)
7.3.3 Europe Acute Spinal Cord Injury Market Size by Application (2016-2027)
7.4 Europe Acute Spinal Cord Injury Market Size by Country
7.4.1 Europe Acute Spinal Cord Injury Market Size by Country (2016-2021)
7.4.2 Europe Acute Spinal Cord Injury Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Spinal Cord Injury Market Size (2016-2027)
8.2 Asia-Pacific Acute Spinal Cord Injury Market Size by Type
8.2.1 Asia-Pacific Acute Spinal Cord Injury Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Spinal Cord Injury Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Spinal Cord Injury Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Spinal Cord Injury Market Size by Application
8.3.1 Asia-Pacific Acute Spinal Cord Injury Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Spinal Cord Injury Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Spinal Cord Injury Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Spinal Cord Injury Market Size by Region
8.4.1 Asia-Pacific Acute Spinal Cord Injury Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Spinal Cord Injury Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Spinal Cord Injury Market Size (2016-2027)
9.2 Latin America Acute Spinal Cord Injury Market Size by Type
9.2.1 Latin America Acute Spinal Cord Injury Market Size by Type (2016-2021)
9.2.2 Latin America Acute Spinal Cord Injury Market Size by Type (2022-2027)
9.2.3 Latin America Acute Spinal Cord Injury Market Size by Type (2016-2027)
9.3 Latin America Acute Spinal Cord Injury Market Size by Application
9.3.1 Latin America Acute Spinal Cord Injury Market Size by Application (2016-2021)
9.3.2 Latin America Acute Spinal Cord Injury Market Size by Application (2022-2027)
9.3.3 Latin America Acute Spinal Cord Injury Market Size by Application (2016-2027)
9.4 Latin America Acute Spinal Cord Injury Market Size by Country
9.4.1 Latin America Acute Spinal Cord Injury Market Size by Country (2016-2021)
9.4.2 Latin America Acute Spinal Cord Injury Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Spinal Cord Injury Market Size (2016-2027)
10.2 Middle East & Africa Acute Spinal Cord Injury Market Size by Type
10.2.1 Middle East & Africa Acute Spinal Cord Injury Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Spinal Cord Injury Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Spinal Cord Injury Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Spinal Cord Injury Market Size by Application
10.3.1 Middle East & Africa Acute Spinal Cord Injury Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Spinal Cord Injury Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Spinal Cord Injury Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Spinal Cord Injury Market Size by Country
10.4.1 Middle East & Africa Acute Spinal Cord Injury Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Spinal Cord Injury Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Acute Spinal Cord Injury Introduction
11.1.4 Novartis Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Oxygen Biotherapeutics
11.2.1 Oxygen Biotherapeutics Company Details
11.2.2 Oxygen Biotherapeutics Business Overview
11.2.3 Oxygen Biotherapeutics Acute Spinal Cord Injury Introduction
11.2.4 Oxygen Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.2.5 Oxygen Biotherapeutics Recent Development
11.3 BioAxone BioSciences
11.3.1 BioAxone BioSciences Company Details
11.3.2 BioAxone BioSciences Business Overview
11.3.3 BioAxone BioSciences Acute Spinal Cord Injury Introduction
11.3.4 BioAxone BioSciences Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.3.5 BioAxone BioSciences Recent Development
11.4 AOSpine International
11.4.1 AOSpine International Company Details
11.4.2 AOSpine International Business Overview
11.4.3 AOSpine International Acute Spinal Cord Injury Introduction
11.4.4 AOSpine International Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.4.5 AOSpine International Recent Development
11.5 Neuronax
11.5.1 Neuronax Company Details
11.5.2 Neuronax Business Overview
11.5.3 Neuronax Acute Spinal Cord Injury Introduction
11.5.4 Neuronax Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.5.5 Neuronax Recent Development
11.6 K-Stemcell
11.6.1 K-Stemcell Company Details
11.6.2 K-Stemcell Business Overview
11.6.3 K-Stemcell Acute Spinal Cord Injury Introduction
11.6.4 K-Stemcell Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.6.5 K-Stemcell Recent Development
11.7 Asterias Biotherapeutics
11.7.1 Asterias Biotherapeutics Company Details
11.7.2 Asterias Biotherapeutics Business Overview
11.7.3 Asterias Biotherapeutics Acute Spinal Cord Injury Introduction
11.7.4 Asterias Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2016-2021)
11.7.5 Asterias Biotherapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acute Spinal Cord Injury Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Imaging Tests
Table 4. Global Acute Spinal Cord Injury Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acute Spinal Cord Injury Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Spinal Cord Injury Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acute Spinal Cord Injury Market Share by Regions (2016-2021)
Table 8. Global Acute Spinal Cord Injury Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acute Spinal Cord Injury Market Share by Regions (2022-2027)
Table 10. Acute Spinal Cord Injury Market Trends
Table 11. Acute Spinal Cord Injury Market Drivers
Table 12. Acute Spinal Cord Injury Market Challenges
Table 13. Acute Spinal Cord Injury Market Restraints
Table 14. Global Acute Spinal Cord Injury Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acute Spinal Cord Injury Market Share by Players (2016-2021)
Table 16. Global Top Acute Spinal Cord Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Spinal Cord Injury as of 2020)
Table 17. Ranking of Global Top Acute Spinal Cord Injury Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acute Spinal Cord Injury Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Spinal Cord Injury Product Solution and Service
Table 21. Date of Enter into Acute Spinal Cord Injury Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acute Spinal Cord Injury Revenue Market Share by Type (2016-2021)
Table 25. Global Acute Spinal Cord Injury Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acute Spinal Cord Injury Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acute Spinal Cord Injury Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acute Spinal Cord Injury Revenue Market Share by Application (2016-2021)
Table 29. Global Acute Spinal Cord Injury Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acute Spinal Cord Injury Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acute Spinal Cord Injury Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acute Spinal Cord Injury Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acute Spinal Cord Injury Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acute Spinal Cord Injury Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acute Spinal Cord Injury Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acute Spinal Cord Injury Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acute Spinal Cord Injury Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acute Spinal Cord Injury Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acute Spinal Cord Injury Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acute Spinal Cord Injury Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acute Spinal Cord Injury Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Spinal Cord Injury Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Spinal Cord Injury Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Spinal Cord Injury Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acute Spinal Cord Injury Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acute Spinal Cord Injury Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acute Spinal Cord Injury Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acute Spinal Cord Injury Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acute Spinal Cord Injury Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acute Spinal Cord Injury Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acute Spinal Cord Injury Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acute Spinal Cord Injury Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Spinal Cord Injury Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Spinal Cord Injury Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Spinal Cord Injury Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acute Spinal Cord Injury Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Acute Spinal Cord Injury Product
Table 64. Novartis Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Oxygen Biotherapeutics Company Details
Table 67. Oxygen Biotherapeutics Business Overview
Table 68. Oxygen Biotherapeutics Acute Spinal Cord Injury Product
Table 69. Oxygen Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 70. Oxygen Biotherapeutics Recent Development
Table 71. BioAxone BioSciences Company Details
Table 72. BioAxone BioSciences Business Overview
Table 73. BioAxone BioSciences Acute Spinal Cord Injury Product
Table 74. BioAxone BioSciences Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 75. BioAxone BioSciences Recent Development
Table 76. AOSpine International Company Details
Table 77. AOSpine International Business Overview
Table 78. AOSpine International Acute Spinal Cord Injury Product
Table 79. AOSpine International Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 80. AOSpine International Recent Development
Table 81. Neuronax Company Details
Table 82. Neuronax Business Overview
Table 83. Neuronax Acute Spinal Cord Injury Product
Table 84. Neuronax Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 85. Neuronax Recent Development
Table 86. K-Stemcell Company Details
Table 87. K-Stemcell Business Overview
Table 88. K-Stemcell Acute Spinal Cord Injury Product
Table 89. K-Stemcell Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 90. K-Stemcell Recent Development
Table 91. Asterias Biotherapeutics Company Details
Table 92. Asterias Biotherapeutics Business Overview
Table 93. Asterias Biotherapeutics Acute Spinal Cord Injury Product
Table 94. Asterias Biotherapeutics Revenue in Acute Spinal Cord Injury Business (2016-2021) & (US$ Million)
Table 95. Asterias Biotherapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Spinal Cord Injury Market Share by Type: 2020 VS 2027
Figure 2. Laboratory Tests Features
Figure 3. Imaging Tests Features
Figure 4. Global Acute Spinal Cord Injury Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Acute Spinal Cord Injury Report Years Considered
Figure 8. Global Acute Spinal Cord Injury Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Acute Spinal Cord Injury Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Acute Spinal Cord Injury Market Share by Regions: 2020 VS 2027
Figure 11. Global Acute Spinal Cord Injury Market Share by Regions (2022-2027)
Figure 12. Global Acute Spinal Cord Injury Market Share by Players in 2020
Figure 13. Global Top Acute Spinal Cord Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Spinal Cord Injury as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Acute Spinal Cord Injury Revenue in 2020
Figure 15. Global Acute Spinal Cord Injury Revenue Market Share by Type (2016-2021)
Figure 16. Global Acute Spinal Cord Injury Revenue Market Share by Type (2022-2027)
Figure 17. North America Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Acute Spinal Cord Injury Market Share by Type (2016-2027)
Figure 19. North America Acute Spinal Cord Injury Market Share by Application (2016-2027)
Figure 20. North America Acute Spinal Cord Injury Market Share by Country (2016-2027)
Figure 21. United States Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acute Spinal Cord Injury Market Share by Type (2016-2027)
Figure 25. Europe Acute Spinal Cord Injury Market Share by Application (2016-2027)
Figure 26. Europe Acute Spinal Cord Injury Market Share by Country (2016-2027)
Figure 27. Germany Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acute Spinal Cord Injury Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Acute Spinal Cord Injury Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Acute Spinal Cord Injury Market Share by Region (2016-2027)
Figure 37. China Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acute Spinal Cord Injury Market Share by Type (2016-2027)
Figure 45. Latin America Acute Spinal Cord Injury Market Share by Application (2016-2027)
Figure 46. Latin America Acute Spinal Cord Injury Market Share by Country (2016-2027)
Figure 47. Mexico Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acute Spinal Cord Injury Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Acute Spinal Cord Injury Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Acute Spinal Cord Injury Market Share by Country (2016-2027)
Figure 53. Turkey Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Acute Spinal Cord Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Novartis Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 57. Oxygen Biotherapeutics Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 58. BioAxone BioSciences Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 59. AOSpine International Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 60. Neuronax Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 61. K-Stemcell Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 62. Asterias Biotherapeutics Revenue Growth Rate in Acute Spinal Cord Injury Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の脊髄刺激システム市場規模・現状・予測（2021年-2027年） The spinal cord stimulation system is also known as a neurostimulation system which provides the therapeutic treatment of the chronic back, neck and extremity pain. The increasing prevalence of chronic and neuropathic pain disorders and the increasing technological advancements to the spinal cord st…- 世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年） Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The glob…
- 世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年） Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The glob…
- 世界の脊椎イメージング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Spinal Imaging Market The global Spinal Imaging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界の脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年） Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement. It's not currently possible to cure spinal muscular at…